“When you have people who like what they do and believe they’re having an impact, you can do anything – more than any project ...
AstraZeneca CEO Sir Pascal Soriot has been awarded one of the highest honours by science institution SCI for his role in ...
Manufacturing giant Lonza has announced an expansion of its service offering for spray-drying of proteins for pulmonary ...
Whether they recognise it or not, the entire pharma industry is involved in the business of health equity and championing it ...
From math hater to a leader in clinical data, it’s been a long journey for Jennifer Visser-Rogers, vice president for ...
When you have people who like what they do and believe they’re having an impact, you can do anything – more than any project ...
Since Roche's Zelboraf (vemurafenib)gained FDA approval in 2011, significant strides have been made in BRAF-targeted cancer ...
AstraZeneca recently announced its £650 million investment in the UK, held up by Chancellor Jeremy Hunt as a ‘vote of ...
Roquette has acquired the pharma solutions division at International Flavors & Fragrances, in a deal up to $2.85 billion.
Lonza is set to acquire a large-scale manufacturing site from Roche-owned U.S. giant Genentech for $1.2 billion.
With the pharma and healthcare landscape increasingly being shaped by artificial intelligence (AI), the US Food and Drug ...
The recent submission of clinical trial data for Sanofi/Regeneron’s Dupixent and Verona’s Ensifentrine to the U.S. FDA indicates the entry of new therapies for chronic obstructive pulmonary disease ...